abrdn Life Sciences Investors - Common (HQL)

CUSIP: 87911K100

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common
Shares outstanding
29,948,325
Total 13F shares
8,708,366
Share change
-460,356
Total reported value
$145,966,923
Price per share
$16.78
Number of holders
72
Value change
-$7,099,873
Number of buys
34
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 87911K100?
CUSIP 87911K100 identifies HQL - abrdn Life Sciences Investors - Common in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of abrdn Life Sciences Investors - Common (HQL) as of Q4 2025

As of 31 Dec 2025, abrdn Life Sciences Investors - Common (HQL) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,708,366 shares. The largest 10 holders included Saba Capital Management, L.P., MORGAN STANLEY, Penserra Capital Management LLC, RAYMOND JAMES FINANCIAL INC, LPL Financial LLC, NEEDHAM INVESTMENT MANAGEMENT LLC, FLAGSHIP HARBOR ADVISORS, LLC, Allspring Global Investments Holdings, LLC, RIVERNORTH CAPITAL MANAGEMENT, LLC, and AMERIPRISE FINANCIAL INC. This page lists 72 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.